First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund (ETF) listed on the New York Stock Exchange Arca. The most recent ex-dividend date was December 13, 2024, with payment scheduled for December 31, 2024. market capitalization is approximately $1.53B.
FBT holds 30 positions, with 0.0% of assets in its ten largest. It charges an expense ratio of 0.55%, and manages $2.77B.
| Holding | Weight |
|---|---|
| BMRNBioMarin Pharmaceutical Inc. | 0.00% |
| BIIBBiogen Inc. | 0.00% |
| NBIXNeurocrine Biosciences, Inc. | 0.00% |
| $USDUS Dollar | 0.00% |
| TGTXTG Therapeutics, Inc. | 0.00% |
| BRKRBruker Corporation | 0.00% |
| REGNRegeneron Pharmaceuticals, Inc. | 0.00% |
| ARGXargenx SE (ADR) | 0.00% |
| BNTXBioNTech SE (ADR) | 0.00% |
| TECHBio-Techne Corporation | 0.00% |